Supplemental Information1 from Evaluation of the SSTR2-targeted Radiopharmaceutical &lt;sup&gt;177&lt;/sup&gt;Lu-DOTATATE and SSTR2-specific &lt;sup&gt;68&lt;/sup&gt;Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma